Cash flow Gedeon Richter OTC Markets

Stocks

GEDS.F

US3684672054

Pharmaceuticals

Market Closed - OTC Markets 15:12:15 2025-07-28 EDT			5-day change	1st Jan Change
30.92 ^USD	+24.45%		-.--%	-

09-18	EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug	MT
08-11	Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026

054e73cb5c401e7039bc37eff70057bc.fy8edYVU6mDhVNDS0LCPh0dlJ76j1vlzFc4HvcHTxPI.HEhIQPQCohq-eeG4toTh6g8UbtOas7A0Jv9A96qAp54LfFAc0TiJC7s5lQ

Published financial data: GEDEON RICHTER

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (HUF)	2022 (HUF)	2023 (HUF)	2024 (HUF)	2025 (HUF)
Revenues	631B	803B	805B	858B	929B
Total Revenues	631B	803B	805B	858B	929B
Cost of Goods Sold, Total	281B	342B	284B	267B	299B
Gross Profit	349B	460B	521B	591B	630B
Selling General & Admin Expenses, Total	143B	182B	197B	221B	223B
Provision for Bad Debts	-	-	-	-	3.24B
R&D Expenses	61B	75.11B	78.34B	99.25B	91.18B
Other Operating Expenses	9.66B	12.35B	29.34B	26.4B	13.31B
Other Operating Expenses, Total	214B	270B	304B	347B	331B
Operating Income	135B	191B	217B	244B	299B
Interest Expense, Total	-663M	-8.03B	-15.34B	-11.97B	-10.52B
Interest And Investment Income	2.96B	13.46B	24.86B	17.66B	15.93B
Net Interest Expenses	2.3B	5.43B	9.52B	5.69B	5.4B
Income (Loss) On Equity Invest.	3.11B	6.15B	6.13B	7.02B	2.69B
Currency Exchange Gains (Loss)	7.6B	7.54B	-37.7B	8.48B	-20.4B
Other Non Operating Income (Expenses)	-1.5B	-6.72B	-1.03B	-2.71B	3.96B
EBT, Excl. Unusual Items	147B	203B	194B	263B	291B
Merger & Related Restructuring Charges	-	-	-	-58.6M	-
Impairment of Goodwill	-5M	-892M	-	-2.7B	-
Gain (Loss) On Sale Of Investments	-758M	-297M	-6.19B	1.44B	1.65B
Gain (Loss) On Sale Of Assets	-	-	11.44B	-	-1.41B
Asset Writedown	-2.59B	-18.97B	-	-491M	-
Other Unusual Items	3.07B	-17.24B	-27.66B	20.25B	-6.56B
EBT, Incl. Unusual Items	147B	166B	172B	281B	285B
Income Tax Expense	5.4B	8.41B	10.89B	41.55B	52.52B
Earnings From Continuing Operations	141B	157B	161B	240B	232B
Net Income to Company	141B	157B	161B	240B	232B
Minority Interest	-1.55B	-1.67B	-1.8B	-280M	107M
Net Income - (IS)	140B	156B	159B	239B	232B
Net Income to Common Incl Extra Items	140B	156B	159B	239B	232B
Net Income to Common Excl. Extra Items	140B	156B	159B	239B	232B
Per Share Items
Net EPS - Basic	750.65	834.96	859.72	1.31K	1.27K
Basic EPS - Continuing Operations	750.65	834.96	859.72	1.31K	1.27K
Basic Weighted Average Shares Outstanding	186M	186M	185M	183M	183M
Net EPS - Diluted	750.65	834.96	859.72	1.31K	1.27K
Diluted EPS - Continuing Operations	750.65	834.96	859.72	1.31K	1.27K
Diluted Weighted Average Shares Outstanding	186M	186M	185M	183M	183M
Normalized Basic EPS	485.08	672.12	646.33	895.36	995.45
Normalized Diluted EPS	485.08	672.12	646.33	895.36	995.45
Dividend Per Share	225	390	431.98	508	-
Payout Ratio	30.03	26.95	45.76	32.95	40.03
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	176B	234B	263B	288B	353B
EBITA	151B	208B	233B	255B	314B
EBIT	135B	191B	217B	244B	299B
EBITDAR	176B	235B	264B	290B	355B
Effective Tax Rate - (Ratio)	3.68	5.08	6.35	14.78	18.44
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	4.4B	11.68B	10.99B	45.16B	44.31B
Total Deferred Taxes	-3.54B	-3.27B	-97M	-3.6B	8.21B
Normalized Net Income	90.23B	125B	119B	164B	182B
Interest on Long-Term Debt	636M	774M	815M	1.08B	1.27B
Non-Cash Pension Expense	122M	122M	355M	230M	220M
Supplemental Operating Expense Items
Selling and Marketing Expenses	115B	147B	146B	164B	166B
General and Administrative Expenses	28.66B	34.86B	50.57B	57.12B	56.66B
Research And Development Expense From Footnotes	61B	75.11B	78.34B	99.25B	91.18B
Net Rental Expense, Total	596M	1.46B	1.8B	2.03B	2.36B
Imputed Operating Lease Interest Expense	61.01M	1.11B	2.56B	2.08B	1.96B
Imputed Operating Lease Depreciation	535M	352M	-767M	-52.22M	397M
Stock-Based Comp., Other (Total)	1.59B	1.55B	1.95B	3.49B	2.05B
Total Stock-Based Compensation	1.59B	1.55B	1.95B	3.49B	2.05B

Fiscal Period: December	2021 (HUF)	2022 (HUF)	2023 (HUF)	2024 (HUF)	2025 (HUF)
Assets
Cash And Equivalents	59.86B	79.72B	80.49B	136B	212B
Short Term Investments	307M	29.35B	6.77B	9M	45.57B
Trading Asset Securities, Total	-	-	140M	-	775M
Total Cash And Short Term Investments	60.16B	109B	87.4B	136B	258B
Accounts Receivable, Total	189B	181B	213B	247B	252B
Other Receivables	16.25B	31.47B	31.93B	29.66B	27.14B
Notes Receivable	1.45B	17.21B	1.23B	1.28B	283M
Total Receivables	206B	230B	246B	278B	280B
Inventory	131B	153B	178B	215B	214B
Prepaid Expenses	4.87B	5.71B	5.74B	6.92B	7.24B
Other Current Assets, Total	9.91B	77.64B	17.78B	5.1B	20.1B
Total Current Assets	413B	576B	535B	641B	779B
Gross Property Plant And Equipment	606B	663B	708B	758B	801B
Accumulated Depreciation	-328B	-347B	-361B	-379B	-417B
Net Property Plant And Equipment	278B	316B	347B	379B	384B
Long-term Investments	183B	166B	182B	184B	152B
Goodwill	35B	35.1B	31.9B	38.78B	42.16B
Other Intangibles, Total	221B	197B	230B	306B	293B
Loans Receivable Long-Term	-	-	755M	682M	723M
Deferred Tax Assets Long-Term	12.28B	15.88B	29.24B	45.66B	39.49B
Deferred Charges Long-Term	0	-	0	0	0
Other Long-Term Assets, Total	2.89B	34.88B	4.82B	7.65B	7.16B
Total Assets	1,145B	1,340B	1,361B	1,603B	1,698B
Liabilities
Accounts Payable, Total	79.64B	46.09B	51.3B	72.33B	55.64B
Accrued Expenses, Total	23.02B	57.05B	34.07B	40.19B	45.05B
Current Portion of Long-Term Debt	3.19B	2.86B	2.72B	4.79B	6.5B
Current Portion of Leases	4.6B	4.44B	4.43B	5.5B	5.81B
Current Income Taxes Payable	2.72B	3.85B	1.97B	25.25B	35.02B
Unearned Revenue Current, Total	1.59B	1.93B	2.35B	2.53B	2.6B
Other Current Liabilities	8.46B	63.29B	17.66B	24.65B	27.66B
Total Current Liabilities	123B	180B	115B	175B	178B
Long-Term Debt	63.78B	67B	66B	74.82B	71.22B
Long-Term Leases	12.72B	10.79B	13.82B	14.62B	14.13B
Unearned Revenue Non Current	6.89B	8.43B	9.41B	9.41B	9.99B
Pension & Other Post Retirement Benefits	5.88B	5.08B	6.56B	6.25B	-
Deferred Tax Liability Non Current	3.8B	3.93B	3.82B	13.33B	13.3B
Other Non Current Liabilities	5.98B	5.2B	4.52B	5.45B	10.42B
Total Liabilities	222B	280B	219B	299B	297B
Common Stock, Total	18.64B	18.64B	18.64B	18.64B	18.64B
Additional Paid In Capital	15.21B	15.21B	15.21B	15.21B	15.21B
Retained Earnings	850B	966B	1,065B	1,219B	1,359B
Treasury Stock	-2.86B	-2.12B	-29.98B	-33.85B	-34.02B
Comprehensive Income and Other	34.16B	51.8B	61.55B	81.53B	39.5B
Total Common Equity	915B	1,050B	1,131B	1,300B	1,398B
Minority Interest	8.14B	10.45B	11.77B	3.4B	2.5B
Total Equity	923B	1,060B	1,143B	1,304B	1,401B
Total Liabilities And Equity	1,145B	1,340B	1,361B	1,603B	1,698B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	186M	186M	183M	182M	182M
ECS Total Common Shares Outstanding	186M	186M	183M	182M	182M
Book Value / Share	4.92K	5.65K	6.19K	7.13K	7.67K
Tangible Book Value	659B	818B	869B	955B	1,063B
Tangible Book Value Per Share	3.55K	4.4K	4.75K	5.24K	5.83K
Total Debt	84.29B	85.08B	86.97B	99.73B	97.65B
Net Debt	24.13B	-23.98B	-434M	-35.9B	-161B
Debt Equivalent Oper. Leases	4.77B	11.67B	14.38B	16.25B	18.86B
Minority Interest, Total (Incl. Fin. Div)	8.14B	10.45B	11.77B	3.4B	2.5B
Equity Method Investments, Total	10.8B	9.28B	15.18B	16.38B	17.52B
Account Code - Inventory Valuation	5	5	6	6	6
Inventories - Raw Materials, Total	66.81B	74.52B	89.03B	122B	104B
Inventories - Work In Process, Total	64.54B	78.81B	88.74B	93.62B	111B
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	205B	221B	234B	269B	303B
Machinery, Total	351B	368B	382B	396B	435B
Full Time Employees	12.26K	12.17K	11.6K	10.94K	11.16K
Accumulated Allowance for Doubtful Accounts (Supple)	4.29B	1.85B	2.12B	2.36B	5.38B

Fiscal Period: December	2021 (HUF)	2022 (HUF)	2023 (HUF)	2024 (HUF)	2025 (HUF)
Net Income	140B	156B	159B	239B	232B
Depreciation & Amortization - CF	29.29B	31.45B	34.48B	38.19B	45.53B
Amortization of Goodwill and Intangible Assets - (CF)	15.63B	17.12B	16.32B	11.33B	14.93B
Depreciation & Amortization, Total	44.92B	48.57B	50.81B	49.52B	60.46B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-1.39B	-	-11.44B	-	1.41B
(Gain) Loss on Sale of Investments - (CF)	-	297M	-	-	-
Asset Writedown & Restructuring Costs	2.59B	19.86B	5.75B	3.24B	-
Stock-Based Compensation (CF)	1.59B	1.55B	-	-	-
Other Operating Activities, Total	-7.15B	1.12B	-13.78B	9.92B	14.39B
Change In Accounts Receivable	-36.47B	-51.31B	-23.2B	-22.42B	-3.51B
Change In Inventories	-20.98B	-38.99B	-27.56B	-29.49B	-9.23B
Change In Accounts Payable	17.17B	48.24B	-15.77B	29.36B	-19.46B
Cash from Operations	140B	185B	124B	279B	276B
Capital Expenditure	-46.13B	-59.23B	-61.96B	-52.93B	-42.58B
Sale of Property, Plant, and Equipment	1.86B	2.81B	3.06B	2.35B	2.56B
Cash Acquisitions	-	-1.26B	-25.13B	-41.81B	-935M
Divestitures	2.12B	-	10.83B	-	1.08B
Sale (Purchase) of Intangible assets	-97.17B	-12.35B	-32.68B	-10.79B	-23.82B
Investment in Marketable and Equity Securities, Total	-112B	-44.2B	33.84B	16.6B	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-1.29B	-18.05B	27.17B	87M	-44.13B
Other Investing Activities, Total	3.65B	13.46B	24.86B	17.66B	15.93B
Cash from Investing	-249B	-119B	-20B	-68.82B	-91.9B
Long-Term Debt Issued, Total	315B	178B	35.94B	219B	-
Total Debt Issued	315B	178B	35.94B	219B	-
Long-Term Debt Repaid, Total	-247B	-182B	-37.08B	-230B	-7.9B
Total Debt Repaid	-247B	-182B	-37.08B	-230B	-7.9B
Repurchase of Common Stock	-819M	-1.33B	-29.8B	-6.94B	-1.99B
Common Dividends Paid	-41.93B	-41.93B	-72.69B	-78.84B	-93B
Common & Preferred Stock Dividends Paid	-41.93B	-41.93B	-72.69B	-78.84B	-93B
Other Financing Activities, Total	-206M	-212M	-177M	-57.89B	-74M
Cash from Financing	25.26B	-46.91B	-104B	-155B	-103B
Foreign Exchange Rate Adjustments	1.6B	1.63B	-46M	-255M	-5.35B
Net Change in Cash	-82.41B	20.82B	-186M	55.13B	76.19B
Supplemental Items
Cash Interest Paid	27M	7.26B	14.52B	10.89B	9.25B
Cash Income Tax Paid (Refund)	8.14B	14.29B	9.74B	23.56B	35.9B
Levered Free Cash Flow	-49.5B	35.52B	38.27B	134B	160B
Unlevered Free Cash Flow	-49.08B	40.54B	47.86B	142B	167B
Change In Net Working Capital	36.89B	57.16B	45.91B	319M	16.69B
Net Debt Issued / Repaid	68.22B	-3.44B	-1.14B	-11.49B	-7.9B

Fiscal Period: December	2021 (HUF)	2022 (HUF)	2023 (HUF)	2024 (HUF)	2025 (HUF)
Profitability
Return on Assets	8.08	9.59	9.99	10.3	11.32
Return on Total Capital	9.19	11.07	11.36	11.59	12.87
Return On Equity %	16.26	15.86	14.5	19.58	17.17
Return on Common Equity	16.22	15.84	14.48	19.68	17.22
Margin Analysis
Gross Profit Margin %	55.39	57.36	64.75	68.89	67.81
SG&A Margin	22.72	22.72	24.42	25.76	23.98
EBITDA Margin %	27.85	29.1	32.61	33.57	38.01
EBITA Margin %	23.94	25.88	28.98	29.79	33.84
EBIT Margin %	21.46	23.75	26.95	28.47	32.23
Income From Continuing Operations Margin %	22.39	19.59	19.95	27.93	25
Net Income Margin %	22.14	19.38	19.73	27.9	25.01
Net Avail. For Common Margin %	22.14	19.38	19.73	27.9	25.01
Normalized Net Income Margin	14.31	15.6	14.83	19.11	19.59
Levered Free Cash Flow Margin	-7.85	4.42	4.75	15.64	17.22
Unlevered Free Cash Flow Margin	-7.78	5.05	5.94	16.51	17.93
Asset Turnover
Asset Turnover	0.6	0.65	0.59	0.58	0.56
Fixed Assets Turnover	2.37	2.7	2.43	2.36	2.44
Receivables Turnover (Average Receivables)	3.66	4.34	4.08	3.73	3.72
Inventory Turnover (Average Inventory)	2.33	2.4	1.71	1.36	1.4
Short Term Liquidity
Current Ratio	3.35	3.21	4.67	3.66	4.37
Quick Ratio	2.15	1.79	2.9	2.35	3.02
Operating Cash Flow to Current Liabilities	1.14	1.03	1.08	1.59	1.55
Days Sales Outstanding (Average Receivables)	99.66	84.11	89.4	98.19	98.08
Days Outstanding Inventory (Average Inventory)	156.61	151.79	212.89	269.68	261.38
Average Days Payable Outstanding	87.73	62.99	57.66	74.31	78.11
Cash Conversion Cycle (Average Days)	168.53	172.9	244.63	293.55	281.35
Long Term Solvency
Total Debt/Equity	9.13	8.02	7.61	7.65	6.97
Total Debt / Total Capital	8.37	7.43	7.07	7.11	6.52
LT Debt/Equity	8.29	7.34	6.99	6.86	6.09
Long-Term Debt / Total Capital	7.59	6.79	6.49	6.37	5.7
Total Liabilities / Total Assets	19.41	20.89	16.06	18.66	17.51
EBIT / Interest Expense	204.15	23.74	14.15	20.4	28.45
EBITDA / Interest Expense	271.9	29.79	17.46	24.54	34.19
(EBITDA - Capex) / Interest Expense	202.33	22.41	13.42	20.11	30.15
Total Debt / EBITDA	0.47	0.36	0.32	0.34	0.27
Net Debt / EBITDA	0.13	-0.1	-0	-0.12	-0.45
Total Debt / (EBITDA - Capex)	0.63	0.47	0.42	0.41	0.31
Net Debt / (EBITDA - Capex)	0.18	-0.13	-0	-0.15	-0.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.26	27.3	0.3	6.51	8.33
Gross Profit, 1 Yr. Growth %	9.57	31.83	13.22	13.31	9.09
EBITDA, 1 Yr. Growth %	10.22	32.99	12.42	7.94	18.32
EBITA, 1 Yr. Growth %	12.11	37.61	13.65	7.58	18.17
EBIT, 1 Yr. Growth %	9.42	40.86	13.83	10.4	17.56
Earnings From Cont. Operations, 1 Yr. Growth %	33.12	11.39	-5.91	49.1	-3.05
Net Income, 1 Yr. Growth %	33.38	11.43	-6.05	50.61	-2.89
Normalized Net Income, 1 Yr. Growth %	15.69	38.97	-5.46	34.32	6.23
Diluted EPS Before Extra, 1 Yr. Growth %	33.35	11.23	-5.25	52.05	-2.8
Accounts Receivable, 1 Yr. Growth %	21.12	-3.87	17.5	15.95	2.09
Inventory, 1 Yr. Growth %	19.34	16.74	15.93	21.18	-0.02
Net Property, Plant and Equip., 1 Yr. Growth %	9.55	13.49	9.95	9.06	1.27
Total Assets, 1 Yr. Growth %	20.74	17.03	0.55	17.76	5.66
Tangible Book Value, 1 Yr. Growth %	3.9	24.15	4.44	10.01	11.88
Common Equity, 1 Yr. Growth %	13.37	14.76	6.34	15	7.53
Cash From Operations, 1 Yr. Growth %	4.78	32.18	-33.51	125.9	-1.06
Capital Expenditures, 1 Yr. Growth %	25	28.41	4.61	-14.58	-19.55
Levered Free Cash Flow, 1 Yr. Growth %	-295.99	-171.34	7	228.26	12.1
Unlevered Free Cash Flow, 1 Yr. Growth %	-291.36	-182.1	17.34	180.7	10.9
Dividend Per Share, 1 Yr. Growth %	0	73.33	10.76	17.6	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.44	19.01	13	3.36	7.41
Gross Profit, 2 Yr. CAGR %	12.13	20.19	22.17	13.27	9.93
EBITDA, 2 Yr. CAGR %	27.46	21.07	22.27	11.02	15.06
EBITA, 2 Yr. CAGR %	33.86	24.21	24.32	11.55	15.05
EBIT, 2 Yr. CAGR %	36.64	24.15	26.63	13.16	16.36
Earnings From Cont. Operations, 2 Yr. CAGR %	70.74	21.77	6.67	18.44	20.23
Net Income, 2 Yr. CAGR %	72.11	21.91	6.66	18.95	20.94
Normalized Net Income, 2 Yr. CAGR %	33.2	26.72	15.12	13.9	22.15
Diluted EPS Before Extra, 2 Yr. CAGR %	72.25	21.79	7.02	20.03	21.57
Accounts Receivable, 2 Yr. CAGR %	9.3	7.91	6.28	16.72	8.8
Inventory, 2 Yr. CAGR %	15.19	18.03	16.34	18.53	9.75
Net Property, Plant and Equip., 2 Yr. CAGR %	6.65	11.5	11.71	9.5	5.09
Total Assets, 2 Yr. CAGR %	15.49	18.87	9.02	8.82	11.69
Tangible Book Value, 2 Yr. CAGR %	8.4	13.57	14.8	7.19	10.62
Common Equity, 2 Yr. CAGR %	12.88	14.06	11.18	10.59	11.2
Cash From Operations, 2 Yr. CAGR %	19.35	17.69	-5.98	22.56	49.5
Capital Expenditures, 2 Yr. CAGR %	8.05	26.69	15.9	-5.47	-17.1
Levered Free Cash Flow, 2 Yr. CAGR %	359	18.6	-12.33	93.63	97.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	324.7	25.72	-1.55	86.31	81.72
Dividend Per Share, 2 Yr. CAGR %	88.98	31.66	38.56	14.13	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.28	16.49	12.41	10.79	4.99
Gross Profit, 3 Yr. CAGR %	11.23	18.35	17.82	19.15	11.01
EBITDA, 3 Yr. CAGR %	20.45	29.27	18.11	17.9	14.77
EBITA, 3 Yr. CAGR %	24.55	35.1	20.11	19.16	15.25
EBIT, 3 Yr. CAGR %	27.25	38.03	20.61	21.73	16.24
Earnings From Cont. Operations, 3 Yr. CAGR %	57.42	48.08	14.85	19.27	10.79
Net Income, 3 Yr. CAGR %	58.08	48.89	14.91	19.66	11.18
Normalized Net Income, 3 Yr. CAGR %	31.66	35.04	15.26	22.06	12.95
Diluted EPS Before Extra, 3 Yr. CAGR %	58.16	48.88	15.16	20.31	11.88
Accounts Receivable, 3 Yr. CAGR %	13.09	4.72	11.02	9.41	11.63
Inventory, 3 Yr. CAGR %	12.32	15.7	17.33	17.93	11.77
Net Property, Plant and Equip., 3 Yr. CAGR %	9.02	8.88	10.98	10.82	6.69
Total Assets, 3 Yr. CAGR %	12.8	16	12.79	11.86	7.85
Tangible Book Value, 3 Yr. CAGR %	10.14	13.41	11.05	13.18	8.52
Common Equity, 3 Yr. CAGR %	10.39	13.5	11.9	12.44	9.56
Cash From Operations, 3 Yr. CAGR %	11.72	23.48	-2.52	25.93	14.12
Capital Expenditures, 3 Yr. CAGR %	3.21	14.45	18.85	4.69	-10.42
Levered Free Cash Flow, 3 Yr. CAGR %	46.06	147.28	14.86	39.13	64.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	45.65	146.06	23.11	42.07	59.84
Dividend Per Share, 3 Yr. CAGR %	31.04	83.61	24.29	31.19	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.1	12.56	12.57	11.05	10.39
Gross Profit, 5 Yr. CAGR %	9.21	12.72	15.48	16.29	14.59
EBITDA, 5 Yr. CAGR %	15.48	17.93	21.18	21.64	17.25
EBITA, 5 Yr. CAGR %	18.23	20.8	24.46	24.84	18.47
EBIT, 5 Yr. CAGR %	20.76	22.99	27	27.49	19.34
Earnings From Cont. Operations, 5 Yr. CAGR %	16.07	73.27	34.73	37.67	16.97
Net Income, 5 Yr. CAGR %	16.1	77.28	35.06	38.39	17.29
Normalized Net Income, 5 Yr. CAGR %	17.28	27.68	24.75	26.36	18.47
Diluted EPS Before Extra, 5 Yr. CAGR %	16.08	77.26	35.28	38.88	17.68
Accounts Receivable, 5 Yr. CAGR %	10.17	8.07	10.31	9.37	10.12
Inventory, 5 Yr. CAGR %	10.08	12.66	13.91	16.82	14.24
Net Property, Plant and Equip., 5 Yr. CAGR %	7.83	9.91	10.08	9.13	8.59
Total Assets, 5 Yr. CAGR %	7.07	11.99	11.28	13.3	12.35
Tangible Book Value, 5 Yr. CAGR %	9.59	12.2	11.99	11.24	10.88
Common Equity, 5 Yr. CAGR %	6.18	9.75	10.7	12.62	11.62
Cash From Operations, 5 Yr. CAGR %	12.56	17.17	4.27	23.25	15.66
Capital Expenditures, 5 Yr. CAGR %	8.59	14.32	8.11	6.02	2.9
Levered Free Cash Flow, 5 Yr. CAGR %	42.72	7.62	19.23	124.54	44.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	40.78	9.96	24.68	120.42	45.38
Dividend Per Share, 5 Yr. CAGR %	16.25	41.81	34	51.81	-